Aligos Therapeutics, Inc. (ALGS) Operating margin 2023–2025
Aligos Therapeutics, Inc. (ALGS) operating margin by fiscal year — reported operating income divided by reported revenue.
-4024.9%FY2025 · since FY2023: -1423.5% → -4024.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4024.9% | -1556.0 pp |
| FY2024 | -2469.0% | -1045.5 pp |
| FY2023 | -1423.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice